Multiple Primary Cutaneous Melanomas in a Bulgarian Patient: The Possible Role of One Step Melanoma Surgery (OSMS) As the Most Adequate Treatment Approach!
DOI:
https://doi.org/10.3889/oamjms.2018.487Keywords:
Melanoma, OSMS, Treatment outcome, Survival benefit, SurgeryAbstract
BACKGROUND: Simultaneous occurrence of multiple primary melanomas is a rare, however possible phenomenon, and it is believed that older, male, white, Atypical Mole Syndrome carriers (sporadic and familial) are part of the possible risk factors for its occurrence. In these patients, it is possible to observe involutional changes or (partial/complete) regression of melanocytic lesions, which are likely to be caused by the generation of a spontaneous immune reaction against specific tumour antigens.
CASE REPORT: A 58-year-old male patient is presented with two melanocytic lesions located in the right clavicle (subclavicular area) and left the scapular area that meets clinically and dermatoscopically the requirements for malignant melanoma. The lesions were removed by a radical excision with 0.5 cm surgical safety margin in all directions. During the subsequent histological verification it was established it was melanoma with a tumour thickness of 1 mm that in one case, and the other 2 mm. A week later, according to the recommendations of the current guidelines, a re-excision was performed with a surgical safety margin of 1.5 cm in all directions. Considering the complications that are possible during the parallel removal of a draining lymph node recommended for these tumour thicknesses, the patient definitively refused its detection and removal.
CONCLUSION: A rare case of a Bulgarian patient with multiple primary, however partially involutional melanomas existing for over 20 years, is described. The individual recommendations of dermato-oncologists for the patient (according to AJCC) were not in favour of radicality but of a more sparing, individualised approach, appropriate for that patient. Unfortunately, the approach we used, in this case, was inconsistent with the AJCC or OSMS guidelines. The reason for individualising the approach in the case we have described is due to the variability of the recommendations for surgical treatment of melanomas laid down in the AJCC.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Ferrone C, Porat L, Panageas K, Berwick M, Halpern A, Patel A, Coit D. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA. 2005; 294(13):1647-54. https://doi.org/10.1001/jama.294.13.1647 PMid:16204664
Johnson T, Hamilton T, Lowe L. Multiple primary melanomas. J Am Acad Dermatol. 1998; 39(3):422-7. https://doi.org/10.1016/S0190-9622(98)70318-4
Tchernev G, Ananiev J, Cardoso J, Chokoeva A, Philipov S, Penev P, Lotti T, Wollina U. Multiple primary cutaneous melanomas in patients with FAMMM syndrome and sporadic atypical mole syndrome (AMS): what's worse? Wien Med Wochenschr. 2014; 164(15-16):302-7. https://doi.org/10.1007/s10354-014-0295-8 PMid:25096163
Fölster-Holst R, Schubert C, Christophers E. [Multiple melanoma in xeroderma pigmentosum]. Hautarzt. 1994; 45(8):554-61. https://doi.org/10.1007/s001050050126 PMid:7960757
Yamada S, Nawata A, Yoshioka M, Hiraki T, Higashi M, Hatanaka K, Tanimoto A. Complete regression of primary cutaneous malignant melanoma associated with distant lymph node metastasis: a teaching case mimicking blue nevus. BMC Res Notes. 2016; 9:366. https://doi.org/10.1186/s13104-016-2174-4 PMid:27456492 PMCid:PMC4960676
Slingluff C, Vollmer R, Seigler H. Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery. 1993; 113(3):330-9. PMid:8441968
Cheng S, Nambi R. Simultaneous occurrence of five primary melanomas and six melanomas in situ in a patient. Clin Exp Dermatol. 2012; 37(2):210-1. https://doi.org/10.1111/j.1365-2230.2011.04171.x PMid:22340700
Remy W, Bockendahl H. [Simultaneous occurrence of two primary melanomas in a patient]. Hautarzt. 1975; 26(6):327-9. PMid:1165196
Savoia P, Quaglino P, Verrone A, Bernengo M. Multiple primary melanomas: analysis of 49 cases. Melanoma Res. 1998; 8(4):361-6. https://doi.org/10.1097/00008390-199808000-00010 PMid:9764812
Moore M, Geller A, Warton E, Schwalbe J, Asgari M. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. J Am Acad Dermatol. 2015; 73(4):630-6. https://doi.org/10.1016/j.jaad.2015.06.059 PMid:26298295
Bower M, Scoggins C, Martin R, Mays M, Edwards M, Reintgen D, Ross M, Urist M, Noyes R, Sussman J, Hagendoorn L, Stromberg A, McMasters K. Second primary melanomas: incidence and outcome. Am Surg. 2010; 76(7):675-81. PMid:20698369
Kricker A, Armstrong B, Goumas C, Thomas N, From L, Busam K, Kanetsky P, Gallagher R, Marrett L, Groben P, Gruber S, Anton-Culver H, Rosso S, Dwyer T, Berwick M; GEM Study Group. Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study. JAMA Dermatol. 2013; 149(8):921-7. https://doi.org/10.1001/jamadermatol.2013.4581 PMid:23784017 PMCid:PMC3815536
Buljan M, Situm M, Bolanca Z, Zivković MV, Mihić L. Multiple primary melanoma: epidemiological and prognostic implications; analysis of 36 cases. Coll Antropol. 2010; 34(Suppl 2):131-4. PMid:21302712
Hwa C, Price L, Belitskaya-Levy I, Ma M, Shapiro R, Berman R, Kamino H, Darvishian F, Osman I, Stein J. Single versus multiple primary melanomas: old questions and new answers. Cancer. 2012; 118(17):4184-92. https://doi.org/10.1002/cncr.27407 PMid:22246969
Helgadottir H, Tuominen R, Olsson H, Hansson J, Höiom V. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status. J Am Acad Dermatol. 2017; 77(5):893-901. https://doi.org/10.1016/j.jaad.2017.05.050 PMid:28818438
Rowe C, Law M, Palmer J, MacGregor S, Hayward N, Khosrotehrani K. Survival outcomes in patients with multiple primary melanomas. J Eur Acad Dermatol Venereol. 2015; 29(11):2120-7. https://doi.org/10.1111/jdv.13144 PMid:25864459
Savoia P, Quaglino P, Verrone A, Bernengo M. Multiple primary melanomas: analysis of 49 cases. Melanoma Res. 1998; 8(4):361-6. https://doi.org/10.1097/00008390-199808000-00010 PMid:9764812
MartÃn J, Pinazo I, Monteagudo C, Markovic J, Allende A, Jordá E. Spontaneous regression of multiple melanocytic nevi after melanoma: report of 3 cases. Am J Dermatopathol. 2014; 36(11):e183-8. https://doi.org/10.1097/DAD.0000000000000033 PMid:25343215
Micksche M, Cerni C, Gebhart W, Kokoschka E. [Halo Nevus (Morbus Sutton): model of an immunological tumor regression]. Osterr Z Onkol. 1975; 2(2-3):73-81. PMid:1243163
Schlabe J, Shah KA, Sheerin F, Payne MJ, Fasanmade AA. Complete spontaneous regression of a metastatic melanoma of the mandible: a case report and follow-up recommendations. International journal of oral and maxillofacial surgery. 2018; 47(12):1519-22. https://doi.org/10.1016/j.ijom.2018.06.007 PMid:29970290
Cervinkova M, Kucerova P, Cizkova J. Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens?. Anticancer Drugs. 2017; 28(8):819-830. https://doi.org/10.1097/CAD.0000000000000526 PMid:28609309
Kappauf H, Esser G. Metachronous Spontaneous Remission of Melanoma Lung Metastasis and Mediastinal Lymph Node Metastases. Oncol Res Treat. 2018; 41(3):135-138. https://doi.org/10.1159/000485626 PMid:29485417
Tokura Y, Yamanaka K, Wakita H, Kurokawa S, Horiguchi D, Usui A, Sayama S, Takigawa M. Halo congenital nevus undergoing spontaneous regression. Involvement of T-cell immunity in involution and presence of circulating anti-nevus cell IgM antibodies. Arch Dermatol. 1994; 130(8):1036-41. https://doi.org/10.1001/archderm.1994.01690080102015 PMid:8053701
Mărgăritescu I, Chiriţă A, Vasilescu F. Completely regressed primary cutaneous melanoma - difficulties in diagnosis and classification. Rom J Morphol Embryol. 2014; 55(2 Suppl):635-42. PMid:25178337
MartÃn J, Pinazo I, Mateo J, Escandell I, Jordá E, Monteagudo C. Assessment of regression in successive primary melanomas. Actas Dermosifiliogr. 2014; 105(8):768-73. https://doi.org/10.1016/j.ad.2014.01.006 PMid:24880710
Ribero S, Osella-Abate S, Sanlorenzo M, Savoia P, Astrua C, Cavaliere G, Tomasini C, Senetta R, Macripò G, Bernengo M, Quaglino P. Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients. Br J Dermatol. 2013; 169(6):1240-5. https://doi.org/10.1111/bjd.12586 PMid:23952011
Fontaine D, Parkhill W, Greer W, Walsh N. Partial regression of primary cutaneous melanoma: is there an association with sub-clinical sentinel lymph node metastasis?. Am J Dermatopathol. 2003; 25(5):371-6. https://doi.org/10.1097/00000372-200310000-00002 PMid:14501285
Dabek R, Baletic N, McUmber H, Nahed B, Haynes A, Eberlin K, Bojovica B. Development of a primary melanoma in situ within a full-thickness skin graft overlying a free muscle flap: a case report. Case Reports Plast Surg Hand Surg. 2018; 5(1):23–26. https://doi.org/10.1080/23320885.2018.1452615 PMid:29707609 PMCid:PMC5917313
Leilabadi S, Chen A, Tsai S, Soundararajan V, Silberman H, Wong A. Update and Review on the Surgical Management of Primary Cutaneous Melanoma. Healthcare (Basel). 2014; 2(2):234-49. https://doi.org/10.3390/healthcare2020234 PMid:27429273 PMCid:PMC4934469
Tchernev G, Chernin S, Lozev I, Lotti T, Stavrov K, Temelkova I, Pidakev I. Innovative One Step Melanoma Surgical Approach (OSMS): Not a Myth-It's a Reality! Case Related Analysis of a Patient with a Perfect Clinical Outcome Reported from the Bulgarian Society for Dermatologic Surgery (BULSDS)! Open Access Maced J Med Sci. 2018; 6(4):673-674. https://doi.org/10.3889/oamjms.2018.194 PMid:29731939 PMCid:PMC5927502
Fernández I, de Troya M, Fúnez R, Rivas F, Blanco G, Blázquez N. Preoperative 15-MHz ultrasound assessment of tumor thickness in malignant melanoma. Actas Dermosifiliogr. 2013; 104(3):227-31. https://doi.org/10.1016/j.adengl.2012.06.025
Tchernev G, Temelkova I, Stavrov K. One Step Melanoma Surgery (OSMS) Without Using Ultrasonography for Preoperative Tumour Thickness Measurement? - "A Question that Sometimes Drives Me Hazy: Am I or Are the Others Crazy!" Open Access Maced J Med Sci. 2018; 6(6):1085-1090. https://doi.org/10.3889/oamjms.2018.236 PMid:29983807 PMCid:PMC6026427
Balch M, Urist M, Karakousis P, Smith J, Temple J, Drzewiecki K, Jewell R, Bartolucci A, Mihm Jr, Barnhill R. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg. 1993; 218(3):262-7. https://doi.org/10.1097/00000658-199309000-00005 PMid:8373269 PMCid:PMC1242959
Balch M, Soong J, Bartolucci A, Urist M, Karakousis P, Smith J, Temple J, Ross I, Jewell R, Mihm C, Barnhill L, Wanebo J. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996; 224(3):255-63. https://doi.org/10.1097/00000658-199609000-00002 PMid:8813254 PMCid:PMC1235362
Tchernev G. One Step Melanoma Surgery for Patient with Thick Primary Melanomas: "To Break the Rules, You Must First Master Them!" Open Access Maced J Med Sci. 2018; 6(2):367–371. https://doi.org/10.3889/oamjms.2018.084 PMid:29531606 PMCid:PMC5839450
Tchernev G. One Step Surgery for Cutaneous Melanoma: "We Cannot Solve Our Problems with the Same Thinking We Used When We Created Them?" Open Access Maced J Med Sci. 2017; 5(6):774–776. https://doi.org/10.3889/oamjms.2017.168
Tchernev G, Chokoeva A. New Safety Margins for Melanoma Surgery: Nice Possibility for Drinking of "Just That Cup of Coffee"? Open Access Maced J Med Sci. 2017; 5(3):352-358. https://doi.org/10.3889/oamjms.2017.068
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Georgi Tchernev, Ivanka Temelkova
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
